Gregory W. Schafer, a member of the Board of Directors of Capricor Therapeutics, Inc., has notified the company that he will not stand for re-election when his term on the Board expires at the company's 2016 Annual Meeting of Stockholders, which is scheduled for June 2, 2016. Mr. Schafer will continue to serve as a member of the Board, as the Chairman of the Audit Committee of the Board and as a member of the Nominating and Corporate Governance Committee of the Board until the Annual Meeting. Mr. Schafer's decision not to stand for re-election is not due to any disagreement with the Company on any of the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.99 USD | -1.32% | -3.39% | +22.49% |
05-17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.49% | 189M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Gregory W. Schafer Not Stand for Re-Election as Member of the Board of Directors of Capricor Therapeutics, Inc